• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Weekly Roundup: January 31-February 4


ICYMI, this week we had stories on skin lightening controversies, what's trending in skin care, and more.

POLL: Are you attending the 2022 AAD meeting in-person this year?

Plaque Psoriasis Patient Case 2: Factors in Selecting 2L Therapy

Shared insight on which factors are most important in determining second-line therapy for plaque psoriasis.

Meet the Aesthetics Expert with Dr. Will Kirby: Alexander Zinovy Rivkin, MD

In this month’s “Meet the Aesthetic Expert” column, Will Kirby, DO, FAOCD, talks with Alexander Zinovy Rivkin, MD, an aesthetic specialist and assistant clinical professor at the David Geffen School of Medicine at UCLA.

What's Trending in Skin Care? January 2022

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of January.

What You Need to Know About Mentoring Doctors

Defining the goals of the mentoring relationship can be useful to clarify expectations.

OSHA, the Needle, and the Fine

In this month's Legal Eagle, we dive into a case of a potential OSHA violation at a practice.

Cosmetic Conundrums & Cleansing Complexities

In this month's Cosmetic Conundrum, Zoe Diana Draelos, MD, dives into common cleanser questions, a topic she also discussed at the Science of Skincare Summit, New York, New York, on November 6, 2021.

Dermatology Times®’ Editorial Advisory Board Member Gets Screen Time in Star Wars: The Book of Boba Fett

Will Kirby, DO, FAOCD, takes an interstellar sidetrip from his Los Angeles-based dermatology practice to the byways of Tatooine for an appearance in Episode VI of this streaming series which airs February 2, 2022 on Disney+.

Legal and Tax Options for a Practice’s Structure

Both legal and tax factors come into play when deciding on the best corporate structure for a dermatology practice.

Get to the Roots of Pediatric Acne

Acne may be the most common skin condition in the United States, with various studies estimating that 79% to 95% of Americans aged 12 to 24 year’s experience at least a minor case, yet diagnosing, treating, and managing care for pediatric patients affected by acne has never been more complex.

How to Explain JAK Inhibitor Warnings to Patients

Experts outline strategies for patient conversations around the black box warning.

Pointers with Dr Portela: Treating Wrinkles with Dr. Azadeh Shirazi

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses the best way to tackle wrinkles with Azadeh Shirazi, MD.

Experts Weigh in on Best Body-Focused Skin Care

Slathering the body with the same skin-care products designed for the face is a bad idea, experts say.

Essential Treatment Tips for Textured Hair

A dermatologist needs to know how to treat every patient, regardless of skin or hair type. These pointers will help guide conversations with patients for the best possible hair care.

Experts Tackle Skin-Lightening Controversy

Unsafe and toxic skin-whitening products continue to draw fire.

The Cutaneous Connection: New Devices for AGA

This episode of The Cutaneous Connection podcast dives into androgenetic alopecia or AGA is a common form of hair loss in both men and women. Maryanne Makredes Senna, MD, assistant professor of dermatology at Harvard Medical school, and director of the Mass General Hospital Hair Loss Clinic and clinical research trials for hair loss disorders in Boston, Massachusetts, highlights current treatment challenges, new regeneration devices, and how to help patients with texture hair.

HS Steps Into Innovation Spotlight

Clinical trials investigate biologics, JAK inhibitors, and additional systemic treatments as first-line alternatives to or adjuvant therapies alongside surgery.

Trevi Therapeutics Completes Enrollment for Haduvio Study

Trevi Therapeutics has completed enrollment for its phase 2b/3 PRISM study in chronic pruritus in prurigo nodularis.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.